SUVRETTA CAPITAL MANAGEMENT, LLC purchased 437.9% of their position (1.48M shares) of BENITEC BIOPHARMA INC. on the open market
Open‑market purchase worth $20.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/10/2025ACC: 0000899140-25-001256
10% Owner
Since Apr 2024
+1.48M
Net shares
Net buyer
$20.00M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
1.48M acquired
Non-Derivative Transactions2
Common stock, par value $0.0001 per share
Indirect
Shares
+730.37K
Price / share
$13.50
Trade value
$9.86M
% of position
8.3%
11/7/2025
8.81M→9.54M
Common stock, par value $0.0001 per share
Indirect
Shares
+751.11K
Price / share
$13.50
Trade value
$10.14M
% of position
70.3%
11/7/2025
1.07M→1.82M
Total
Net shares
+1.48M
Net value
$20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.0001 per share Indirect | 11/7/2025 | P · Purchase | +730.37K | $13.50 | $9.86M | 8.3% | 8.81M | 9.54M |
| Common stock, par value $0.0001 per share Indirect | 11/7/2025 | P · Purchase | +751.11K | $13.50 | $10.14M | 70.3% | 1.07M | 1.82M |
| Total | +1.48M | $20M | ||||||
Derivative Transactions0
No derivative transactions reported